Malin

Malin Corporation plc is a strategic life sciences investment company with a mission to build and support high-potential healthcare businesses to create shareholder value. Founded in 2014, it employs an active, long-term partnership model, taking significant stakes in private and public companies within biologics, oncology, and rare diseases. Its strategy centers on de-risking through portfolio diversification and hands-on management, aiming for value-creating exits via trade sales or IPOs. Key achievements include building a focused portfolio and leveraging its team's deep industry experience to navigate portfolio companies from development to commercialization.

Malin's core platform is its integrated investment and operational model, providing strategic capital, active portfolio management, and hands-on operational expertise to build and scale life sciences companies.

Malin competes with traditional VC firms, corporate venture arms, and incubators, differentiating itself through active, long-term ownership and deep operational support. Its hybrid model of a publicly-listed, focused company-builder is relatively unique in the market.